aTYR PHARMA INC ATYR
aTYR PHARMA INC statistics & valuation
Market cap$51.7M
P / B0.8×
Net margin-39009.5%
Return on equity-109.8%
FCF margin-32664.7%
Return on capital-99.7%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -40856.3% | -28899.6% | -15557.8% | -446.8% | — | -152.2% | -5445.0% | — | — | — |
| Net margin | -39009.5% | -27243.8% | -14274.5% | -436.5% | — | -155.2% | -3844.5% | — | — | — |
| FCF margin | -32664.7% | -29440.0% | -10605.1% | -419.1% | — | -148.3% | -4761.1% | — | — | — |
| Return on assets | -79.7% | -66.1% | -41.8% | -47.3% | -29.2% | -41.9% | -44.8% | -65.4% | -53.9% | -71.8% |
| Return on equity | -109.8% | -91.4% | -55.6% | -63.4% | -30.9% | -51.3% | -76.6% | -102.6% | -75.0% | -92.1% |
| Debt / equity | — | — | — | — | — | — | — | 0.25× | 0.23× | 0.15× |
| Current ratio | 5.30 | 5.48 | 6.27 | 5.83 | 18.89 | 6.06 | 2.47 | 4.69 | 8.37 | 8.77 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.